Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
Trial record 1 of 1 for:    cusp 9
Previous Study | Return to List | Next Study

A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02770378
Recruitment Status : Active, not recruiting
First Posted : May 12, 2016
Last Update Posted : October 17, 2019
Sponsor:
Collaborators:
Reliable Cancer Therapies
Anticancer Fund, Belgium
Information provided by (Responsible Party):
Marc-Eric Halatsch, University of Ulm

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : October 2018
Estimated Study Completion Date : March 2020